Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

Breast cancer and Lasofoxifene

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Breast cancer and Lasofoxifene

Breast cancer vs. Lasofoxifene

Breast cancer is cancer that develops from breast tissue. Lasofoxifene, sold under the brand name Fablyn, is a nonsteroidal selective estrogen receptor modulator (SERM) which is marketed by Pfizer in Lithuania and Portugal for the prevention and treatment of osteoporosis and for the treatment of vaginal atrophy,https://www.drugs.com/international/lasofoxifene.html and the result of an exclusive research collaboration with Ligand Pharmaceuticals (LGND).

Similarities between Breast cancer and Lasofoxifene

Breast cancer and Lasofoxifene have 6 things in common (in Unionpedia): Aromatase inhibitor, Estrogen receptor, Metastatic breast cancer, Raloxifene, Selective estrogen receptor modulator, Tamoxifen.

Aromatase inhibitor

Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and gynecomastia in men.

Aromatase inhibitor and Breast cancer · Aromatase inhibitor and Lasofoxifene · See more »

Estrogen receptor

Estrogen receptors (ERs) are a group of proteins found inside cells.

Breast cancer and Estrogen receptor · Estrogen receptor and Lasofoxifene · See more »

Metastatic breast cancer

Metastatic breast cancer, also referred to as metastases, advanced breast cancer, secondary tumours, secondaries or stage 4 breast cancer, is a stage of breast cancer where the disease has spread to distant sites beyond the axillary lymph nodes.

Breast cancer and Metastatic breast cancer · Lasofoxifene and Metastatic breast cancer · See more »

Raloxifene

Raloxifene, developed by Eli Lilly in 1997 and sold under the brand name Evista among others, is a medication which is used in the prevention and treatment of osteoporosis in postmenopausal women and to reduce the risk of breast cancer in postmenopausal women with osteoporosis or at high risk for breast cancer.

Breast cancer and Raloxifene · Lasofoxifene and Raloxifene · See more »

Selective estrogen receptor modulator

Selective estrogen receptor modulators (SERMs) are a class of drugs that act on the estrogen receptor (ER).

Breast cancer and Selective estrogen receptor modulator · Lasofoxifene and Selective estrogen receptor modulator · See more »

Tamoxifen

Tamoxifen (TMX), sold under the brand name Nolvadex among others, is a medication that is used to prevent breast cancer in women and treat breast cancer in women and men.

Breast cancer and Tamoxifen · Lasofoxifene and Tamoxifen · See more »

The list above answers the following questions

Breast cancer and Lasofoxifene Comparison

Breast cancer has 264 relations, while Lasofoxifene has 33. As they have in common 6, the Jaccard index is 2.02% = 6 / (264 + 33).

References

This article shows the relationship between Breast cancer and Lasofoxifene. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »